Definitive Contract 75A50124C00050
Award Date
9/27/24
Potential Completion Date
9/29/25
Potential Value
$613K
Awardee
Grifols Therapeutics LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Department of Veterans Affairs Veterans Health Administration (VHA) Veterans Integrated Service Network 19 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The order, valued at $149,274.24, is for the provision of pharmaceutical products to the VHA under the Pharmaceuticals and Drugs GSA Schedule contract. The order does not utilize any small business set-asides. Grifols, a well-established...
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $84,612.48, was issued under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) and involves the procurement of various pharmaceutical products such as Prolastin, Prolastin-C, and immune globulin. The contract has an ultimate completion date of May 25, 2017 and does...
This is a federal contract award from the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, a delivery order under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule, is for the drug Prolastin. The contract has a firm fixed price of $179,764.80 and a period of performance ending on September 30, 2017. The contract was awarded on October 1, 2016 and was not...
This is a firm fixed-price blanket purchase agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The award, valued at $88,732.32, is to provide express pharmaceutical orders for the VA's Network 19 pharmacy operations. The contract is under the Pharmaceuticals and Drugs GSA Schedule and does not utilize any small business set-asides. Grifols has previously...
This is a delivery order issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biopharmaceuticals. The $278,987.52 firm fixed price award is for the provision of unspecified DRUG products under the Pharmaceuticals and Drugs GSA Schedule contract. The order has a period of performance ending on March 15, 2017 and does not utilize a small business set-aside....
This federal contract award was made by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the delivery of medication, specifically pharmaceuticals such as Prolastin, Prolastin-C, and immune globulin. The contract type is a Blanket Purchase Agreement (BPA) Call, with a Firm Fixed Price pricing structure. The...
This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The $639,352.61 Blanket Purchase Agreement (BPA) call contract is for the delivery of medication, specifically pharmaceuticals and drugs, under the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule. The contract does...
This federal contract award is a delivery order issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The order is for various pharmacy supplies and pharmaceuticals, including Prolastin, Prolastin-C, and immune globulin, under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. The total...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Grifols Biologicals LLC, a global healthcare company that provides plasma-derived medicines and transfusion medicine. The contract, valued at $139,708.50, is a delivery order under the VA's Pharmaceutical and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The award is for the provision of "FLEBOGRAMM" products, with an ultimate completion date of December 13, 2016. The contract does not...
This is a $319,369.68 delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biopharmaceuticals. The contract, which is not set aside, is for the delivery of the pharmaceutical product PROLASTIN C. It is a firm fixed price contract with a period of performance ending on September 30, 2020. Grifols Therapeutics LLC is a long-standing federal contractor, having...